Company / R&D per Share
Edwards Lifesciences R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.86
FY2025
5-year range
$1.39 / $1.86
FY2021-FY2025
Trend
+6.1%
vs FY2024
Sector context
#50 of 108
Health Care
What the data says
At $1.86, Edwards Lifesciences's r&d per share ranks #50 of 108 in the Health Care sector. R&D per Share has increased for 3 consecutive years, from $1.39 in FY2022 to $1.86 in FY2025.
Based on SEC 10-K filings.
1.86 in FY2025 with a 5-year CAGR of +8.8%.
Improved from $1.48 to $1.86 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +10.2%
- 5-Year CAGR
- +8.8%
- 10-Year CAGR
- -
Sector benchmark
#50 of 108 in Health CareTop 46% of 108This company $1.86 Sector average $2.07
▼
-10.2% below sector average
Key checks
Key Insights
- Edwards Lifesciences's r&d per share has grown for 3 consecutive years.
- In FY2025, r&d per share increased 6.1% year-over-year.
- Ranks #50 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.86 | +6.1% |
| FY2024 | $1.75 | +18.0% |
| FY2023 | $1.48 | +7.1% |
| FY2022 | $1.39 | -4.2% |
| FY2021 | $1.45 | +18.8% |
| FY2020 | $1.22 | -66.2% |
| FY2019 | $3.60 | +20.2% |
| FY2018 | $3.00 | +14.7% |
| FY2017 | $2.61 | +25.0% |
| FY2016 | $2.09 | -41.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026